Lipella Pharmaceuticals Inc. Common Stock (LIPO)

Lipella Pharmaceuticals Inc. Common Stock (LIPO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2,310; returns 1 day +0.0%, 1 year -99.9%.

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on developing novel therapeutic solutions by reformulating active agents from existing generic drugs. The company leverages its proprietary lipid-based drug delivery platform for targeted tissue delivery, primarily addressing mucosal and urologic disorders.

Groups LIPO belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Clinical Stage
• Pharmaceuticals
• Drug Discovery
• Rare Diseases
• Autoimmune Diseases
• Generics
• Life Sciences

LIPO financial model: income statement, cash flow and balance sheet